protein

Biotech

Leaps by Bayer leads $40M Gandeeva funding

For the third time this week, Leaps by Bayer is contributing to another biotech's funding, this time for protein imaging and disease identification.
Sophia Sorensen Jan 31, 2022 8:00am

Fighting drug-resistant cancer by blocking an escape route

Jan 5, 2022 8:35am

Flagship-incubated Generate reels in $370M for protein therapies

Nov 18, 2021 5:00am

Novartis inks protein degrader deal with new British startup

Nov 2, 2021 5:00am

EQRx's affordable drug drive leads to Absci discovery pact

Oct 6, 2021 8:20am

Vanderbilt team offers new clues for targeting p53

Sep 1, 2021 9:50am